CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati - Pharmaceutical Technology

The tender offer is for €51.29 per share, representing a 13% premium on Recordati’s share price before the takeover was first disclosed. The tender offer is for €51.29 per share, representing a 13% premium on Recordati’s share price before the takeover was first disclosed. Many of Italy’s large pharma companies are privately owned. Credit: esfera/Shutterstock.com. One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm CVC Capital Partners and Belgian investment group Groupe Bruxelles Lambert (BGL) launched a $12.4bn (€10.7bn) takeover bid for Recordati. At the end of March, CVC…

Source: Pharmaceutical Technology